Beating-Heart Transplant UK First
The new technique involves keeping a donated heart warm and beating throughout the procedure, rather than packing it in ice for transport.
Article
European Medicines Evaluation Agency Grants Mologen AG Medicine Status for Their Cell-Based Gene Therapy
Mologen AG announces that they obtained medicine status for their cell-based gene therapy against kidney cancer. This status was granted by Innovation Task Force (ITF), a committee of the European medicines evaluation agency, EMEA.
Article
Approval Granted for Harvard Stem Cell Institute Researchers to Attempt Creation of Disease-Specific Embryonic Stem Cell Lines
After more than two years of intensive ethical and scientific review, Harvard Stem Cell Institute (HSCI) researchers at Harvard and Children’s Hospital Boston have been cleared to begin experiments using Somatic Cell Nuclear Transfer (SCNT) to create disease-specific stem cell lines in an effort to develop treatments for a wide range of now-incurable conditions afflicting tens of millions of people.
Article
Cardium Reports Meta-Analysis of Angiogenic Gene Therapy Studies Shows Positive Effects in Men and Women With Heart Disease
Several positive findings have emerged from a review of the AGENT clinical data, which relates to the Company’s lead product candidate, Generx(TM) (Ad5FGF-4).
Article
Oxxon Therapeutics HI-8â„¢ MEL Therapeutic Vaccine Demonstrates Potential For Treatment of Metastatic Melanoma
The Phase II dose-escalation study has met its clinical endpoints, demonstrating that immunisation with Oxxon’s Hi-8(TM) MEL therapeutic vaccine is well tolerated at all doses and shows clinical benefit in HLA-A2 positive patients.
Article
Oxford BioMedica PLC Reports New Encouraging Phase II Results With Trovax® And Progress In The Development Plan
Oxford BioMedica, a leading gene therapy company, has reported that encouraging data from five Phase II studies of TroVax, its lead cancer immunotherapy product, were presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO).
Article
Biovest International Presents Long Term Follow up Data on BiovaxID(TM) Treatment of Follicular Non-Hodgkin’s Lymphoma at American Society for Clinical Oncology Meeting
Biovest International Inc. delivered a presentation entitled “Idiotype Vaccine Therapy of Follicular Lymphoma in First Remission: Association of t(14;18) and Disease Free Survival in a Phase II Cohort” at the annual meeting of the American Society for Clinical Oncology in Atlanta, GA.
Article
Biovest International, Inc. To Expand BiovaxID Phase III Trial In Ukraine And Russia; Regulatory Documents Filed
Biovest International, Inc. has filed for regulatory approval to open up to 30 new clinical sites for its pivotal Phase III trial of BiovaxID(TM) for the treatment of follicular non-Hodgkin’s lymphoma (NHL) — a major milestone for the Company.
Article
Antigenics Presents Phase III Data from Trial of Oncophage in Metastatic Melanoma at ASCO Meeting
The overall median survival was 29 percent longer in patients who received at least 10 injections of oncophage. A combined population of stage IV M1a and M1b melanoma patients who received at least 10 vaccinations experienced increased survival of 143 percent.
Article
Reovirus Could Be Used to Treat Many Forms of Advanced Cancer
In a world first, 30 patients received various intravenous dosages of Reolysin in a Phase I trial in the United Kingdom. The results demonstrated that Reolysin may have stopped the growth of tumors in some patients, or even shrunk tumors, without the side effects normally associated with more traditional forms of cancer therapy.
Article
Cell Genesys and Medarex Announce Encouraging Interim Results from a Phase 1 Combination Therapy Trial With GVAX(R) Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
Cell Genesys, Inc. and Medarex, Inc. have announced encouraging data from a Phase 1 clinical trial of Cell Genesys’ GVAX® immunotherapy for prostate cancer, administered in combination with Medarex’s fully human anti-CTLA-4 antibody, ipilimumab (MDX- 010), in patients with advanced prostate cancer.
Article
Key To Future Stem Cell Production May Lie Inside The Testicles
British scientists have been granted permission to investigate whether stem cells found deep inside testicles can be used to repair damaged tissues and organs.
Article
Gene Silencing Directs Muscle-derived Stem Cells To Become Bone-forming Cells
Using a relatively new technology called RNA interference to turn off genes that regulate cell differentiation, University of Pittsburgh researchers have demonstrated they can increase the propensity of muscle-derived stem cells (MDSCs) to become bone-forming cells.
Article
Cell Therapy Technologies Announces Successful Use of Cord Blood Stem Cells to Prevent Oxygen Induced Lung Damage in a Neonatal Rat Model
This is the first demonstration in the world of the ability of cultured cord blood stem cells to prevent oxygen toxicity in the lung in a neonatal rat model.
Article
Islet Cell Transplantation Significantly Improves Glycemic Control in Diabetes
Patients with type 1 diabetes who receive transplants of insulin-producing islet cells have significantly more stable blood glucose levels and fewer hypoglycemic episodes.
Article
Gene Therapy Completely Suppresses Ovarian Cancer Growth in Animal Model
University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer.
Article
Mouse Study Shows Gene Therapy Provides Temporary Protection from Radiation
University of Pittsburgh School of Medicine researchers have successfully protected mice against the damaging effects that radiation can have on bone marrow using gene therapy.
Article
Gene Therapy Prevents The Onset Of Diabetic Symptoms In Mice
Using state-of-the-art gene therapy techniques, University of Pittsburgh investigators have successfully prevented the onset of elevated blood sugar, or hyperglycemia, in diabetes-prone mice by inserting a gene encoding for a cytokine—a protein that stimulates or inhibits the proliferation or function of immune cells—into their insulin-producing cells.
Article
Muscle Bound: Gene Therapy Significantly Accelerates Healing of Damages Skeletal Muscle in Experimental Model
University of Pittsburgh School of Medicine researchers have successfully used gene therapy to accelerate muscle regeneration in experimental animals with muscle damage, suggesting this technique may be a novel and effective approach for improving skeletal muscle healing, particularly for serious sports-related injuries.
Article
Bone Marrow May Restore Cells Lost in Vision Diseases
University of Florida scientists conducting experiments with mice have found evidence that the body naturally replenishes small amounts of cells in the eye essential for healthy vision.
Article
Origen Therapeutics Publishes in Nature a Robust and Versatile Method for Creating Transgenic Chickens
Origen Therapeutics announced today that it has succeeded in developing a robust and versatile technology for genetically modifying chickens that, for the first time, puts avian transgenics on a par with transgenic mice.
Article
ABSTRACTS, REVIEWS & SPECIAL REPORTS
Germline Transmission of Genetically Modified Primordial Germ Cells
The researchers show that chicken Primordial germ cells (PGCs) can be isolated, cultured and genetically modified while maintaining their commitment to the germ line. Furthermore, they show that chicken PGCs can be induced in vitro to differentiate into embryonic germ cells that contribute to somatic tissues.
Article